J. B. Chemicals and Pharmaceuticals Limited Revenue and Competitors
Employee Data
- J. B. Chemicals and Pharmaceuticals Limited has 808 Employees.
- J. B. Chemicals and Pharmaceuticals Limited grew their employee count by 8% last year.
J. B. Chemicals and Pharmaceuticals Limited's People
| Name | Title | Email/Phone |
|---|
What Is J. B. Chemicals and Pharmaceuticals Limited?
J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India's leading pharmaceutical companies. An integrated, public listed organization with a focus on supplying affordable, quality products both in India and International markets.
keywords:N/A
N/A
Total Funding
808
Number of Employees
N/A
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
J. B. Chemicals and Pharmaceuticals Limited News
Sequoia invested about ?100 crore in Curatio Healthcare in 2014. Torrent Pharmaceuticals and KKR-controlled JB Chemicals are among the final...
Brands such as Sporlac, Lobun, Oxalo, Pubergen, Nano-Leo, and Gynogen are now part of JB Chemicals' franchise and the turnover of these brands...
J B Chemicals & Pharmaceuticals Ltd., incorporated in the year 1976, is a Mid Cap company (having a market cap of Rs 12256.17 Crore) operating...
J.B. Chemicals and Pharmaceuticals Ltd. Q1 FY22 Earnings Conference Call August 13, 2021 This transcript is published as is what we have received from our vendor who manages the conference call. We would request you to go through the audio recording in case you want to reconfirm anything that ...
J.B. Chemicals & Pharmaceuticals Limited Q4 and FY21 Earnings Conference Call Transcript June 15, 2021 Moderator:Ladies and Gentlemen, Good Day and Welcome to Q4 and FY21 Earnings conference call of J.B. Chemicals & Pharmaceuticals Limited. As a reminder, all participant lines will be in the ...
Other Companies in mumbai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $143M | 814 | 6% | N/A |
#2 | $120.5M | 820 | 27% | N/A |
#3 | N/A | 822 | 21% | N/A |
#4 | $83.7M | 825 | 5% | N/A |
#5 | $119.2M | 831 | 2% | N/A |